IgM Nephropathy: A Question of Existence in the Domain of Glomerular Diseases; A Case Series
DOI:
https://doi.org/10.21276/apalm.3662Keywords:
Renal biopsy, Immunofluorescence, nephropathyAbstract
Background: Immunoglobulin M nephropathy (IgMN) is a rare glomerular disease characterized by isolated IgM deposits in the glomeruli. Its clinical presentation and prognosis remain controversial, often overlapping with other glomerular diseases like minimal change disease (MCD). This is a case series describing the clinical and pathological features of patients diagnosed with IgMN at our tertiary care center.
Materials and Methods: A retrospective review of renal biopsies performed between January 2023 and December 2023 was conducted. Patients diagnosed as IgMN were included. Clinical data, laboratory parameters, histopathological findings, immunofluorescence results, treatment regimens, and follow-up data were collected.
Results: Five patients (four females, one male) were diagnosed with IgMN. The majority presented with nephrotic syndrome with frequent relapses, and steroid dependence. Histopathological examination revealed mesangial hypercellularity and matrix expansion. Immunofluorescence staining showed diffuse 2+/3+ mesangial IgM deposits. Treatment with corticosteroids and rituximab resulted in clinical improvement and stabilization of renal function.
Conclusion: IgMN is a distinct clinical entity with a variable clinical course. Early recognition and appropriate treatment, including immunosuppressive therapy, are crucial for achieving remission and preventing disease progression. Further research is needed to better understand the pathogenesis and optimal management of IgMN.
References
1. Mubarak M, Kazi JI. IgM nephropathy revisited. Nephrourol Mon. 2012 Fall;4(4):603-8. doi:10.5812/numonthly.2805.
2. Cohen AH, Border WA, Glassock RJ. Nephrotic syndrome with glomerular mesangial IgM deposits. Lab Invest. 1978;38(5):610-9.
3. Bhasin HK, Abuelo JG, Nayak R, Esparza AR. Mesangial proliferative glomerulonephritis. Lab Invest. 1978;39(1):21-9.
4. Salmon AH, Kamel D, Mathieson PW. Recurrence of IgM nephropathy in a renal allograft. Nephrol Dial Transplant. 2004;19(10):2650-2. doi: 10.1093/ndt/gfh434.
5. Mokhtar GA. IgM nephropathy: clinical picture and pathological findings in 36 patients. Saudi J Kidney Dis Transpl. 2011:22(5):969-75.
6. Chae Y, Kim Y, Kim Y, Kim Y, Kim Y, Kim Y, et al. Renal Outcome of IgM Nephropathy: A Comparative Prospective Cohort Study. Journal of Clinical Medicine. 2021;10(18):4191.
7. Connor TM, Smith SW, Smith SW, Smith SW, Smith SW, Smith SW, et al. The natural history of immunoglobulin M nephropathy in adults. Nephrol Dial Transplant. 2016;32:823-829.
8. Al-Eisa A, Al-Eisa A, Al-Eisa A, Al-Eisa A, Al-Eisa A, Al-Eisa A, et al. Clinical Picture and Pathological Findings in Immunoglobulin M Nephropathy: A Study of 36 Patients. Saudi J Kidney Dis Transpl. 2011;22(5):969-975.
9. Khosroshahi A, Khosroshahi A, Khosroshahi A, Khosroshahi A, Khosroshahi A, Khosroshahi A, et al. Immunoglobulin M nephropathy complicated by cerebral venous sinus thrombosis: a case report and literature review. BMC Nephrol. 2020 21(1):93.
10. Ota K. Ota K. Ota K. Ota K. Ota K, Ota K, et al. A case report of immunoglobulin M nephropathy manifesting as crescentic glomerulonephritis with nephritic syndrome. BMC Nephrol. 2019;20(1):181.
11. Myllymaki J, Long-term outcomes of IgM nephropathy in children vs minimal change disease: a retrospective cohort study from Finland. Pediatr Nephrol.
12. Al-Eisa A, Al-Eisa A, Al-Eisa A, Al-Eisa A, Al-Eisa A, Al-Eisa A, et al. Childhood IgM nephropathy: comparison with minimal change disease. Nephron. 1996;72(1):37-43.
13. Maruyama M. Maruyama M, Maruyama M, Maruyama M, Maruyama M, Maruyama M, et al. Clinical significance of IgM deposition in the mesangium and mesangial hypercellularity in adult minimal change nephrotic syndrome. Nippon Jinzo Gakkai Shi. 2006 48(1):14-21.
14. Heptinstall's Pathology of the Kidney, 6th ed., LWW, Philadelphia, 2007, p. 144.
15. Hsu HC, Chen WY, Lin GJ, Chen L, Kao SL, Huang CC, et al. Clinical and immunopathologic study of mesangial IgM nephropathy: report of 41 cases. Histopathology. 1984:8(3):435-46. doi: 10.1111/j.1365-2559.1984.tb02355.x.
16. Zeis PM, Zeis PM, Zeis PM, Zeis PM, Zeis PM, Zeis PM, et al. Glomerulopathy with mesangial IgM deposits: long-term follow up of 64 children. Pediatr Int. 2001 Jun;43(3):287-92.
17. Alexopoulos E, Alexopoulos E, Alexopoulos E, Alexopoulos E, Alexopoulos E, Alexopoulos E, et al. Adult-onset idiopathic nephrotic syndrome associated with pure diffuse mesangial hypercellularity. Nephrol Dial Transplant. 2000 Jul;15(7):981-7.
18. Brugnano R. Brugnano R, Brugnano R, Brugnano R, Brugnano R, Brugnano R, et al. IgM nephropathy: is it closer to minimal change disease or to focal segmental glomerulosclerosis? J Nephrol. 2016 Aug;29(4):479-86.
19. Arias LF, Arias LF, Arias LF, Arias LF, Arias LF, Arias LF, et al. IgM nephropathy in children: clinicopathologic analysis. Nefrologia. 2013 33(4):532-8.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ambili R Nath, Nikita James, Meeta Thomas, Rebecca Mathews, Lillykutty Pothen
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
